CD82 and esophageal squamous cell carcinoma: In ESCC cells, overexpression of KAI1/CD82 significantly decreased TGF-β1/Smad signal pathway, including TGF-β1, Smad2/3, MMP-2, and MMP-9 level, and thus decreased cell proliferation, invasion, and metastasis [31].